Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Most Download

  • Published in last 1 year
  • In last 2 years
  • In last 3 years
  • All
  • Most Downloaded in Recent Month
  • Most Downloaded in Recent Year
Please wait a minute...
  • 1.
    Progress in clinical management of anastomotic leakage after esophageal cancer surgery
    Kaiyuan Zhu, Zhigang Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (01): 50-56. DOI: 10.3877/cma.j.issn.2095-8773.2023.01.09
    Abstract (384) HTML (29) PDF (1172 KB) (79)

    Esophageal carcinoma is one of the most common malignant tumors in China. At present, the main treatment regimen for resectable esophageal cancer is still surgery. Anastomotic leakage is a common complication after esophagectomy. Its clinical manifestations are extremely complex, ranging from asymptomatic to sepsis with multiple organ failure. The occurrence of anastomotic leakage will increase the 90-day mortality of patients and impose medical and financial burden to physicians and patients. The prevention of anastomotic leakage and the rational choice of treatment can benefit patients significantly. Currently, the clinical treatment of postoperative anastomotic leakage mainly includes conservative treatment, non-operative treatment and operative treatment. It is generally believed that the treatment should be chosen according to the characteristics of anastomotic leakage, but there is no consensus on which treatment benefits the patients most. Therefore, more clinical data are currently needed to prove the advantages of a certain treatment for definite indications, so as to assist the physicians to make the optimal choice.

  • 2.
    2021 Chinese expert consensus on perioperative immunotherapy for esophageal cancer
    National Cancer Center, Chinese Association of Thoracic Surgeons, Chinese Society for Thoracic and Cardiovascular Surgery
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2022, 09 (01): 12-22. DOI: 10.3877/cma.j.issn.2095-8773.2022.01.02
  • 3.
    Chinese expert consensus for robot-assisted esophagectomy (2023 edition)
    The Society of Esophageal Cancer, Chinese Anti-Cancer Association
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2024, 11 (01): 1-15. DOI: 10.3877/cma.j.issn.2095-8773.2024.01.01
    Abstract (138) HTML (8) PDF (1255 KB) (54)

    With the application of robot-assisted technology in esophageal surgery, the number of domestic centers carrying out robot-assisted esophagectomy in China has gradually increased, and the feasibility and safety of robot-assisted esophagectomy have also been confirmed by the continuously updated research. For the standard application and development of this surgical procedure, the Committee of Esophageal Cancer in China Anticancer Association has developed this expert consensus based on the "Chinese Clinical Expert Recommendations for Robot-assisted Esophagectomy (2019 edition) " in 2019, further combined with newly published literature from China and abroad, and the surgical treatment principles of esophageal cancer and standardized techniques for minimally invasive operation, so as to guide the standard application of robot-assisted technology in minimally invasive esophagectomy in China.

  • 4.
    Overview of pulmonary nodules positioning methods
    Han Tang, Qun Wang, Lijie Tan, Di Ge, Yunfeng Yuan
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2022, 09 (02): 100-103. DOI: 10.3877/cma.j.issn.2095-8773.2022.02.06
    Abstract (180) HTML (14) PDF (1262 KB) (48)

    With the widespread use of chest computed tomography (CT) in physical examination, more and more potential malignant pulmonary nodules are detected. For those nodules that required surgical intervention, localizing the nodules precisely is the key to the success of the surgery. At present, many positioning methods are in use, such as CT-guided percutaneous localization, electromagnetic navigation bronchoscopy positioning, anatomical positioning and intraoperative ultrasonography positioning, and the localization materials include hook-wire, microcoils, colouring agents, biomedical glue and so on. However, there are instinct flaws among these multiple methods. Therefore, it is of great importance to summarize the indications of these methods so as to select appropriate one for certain pulmonary nodules.

  • 5.
    Acceptance of Japanese esophageal cancer practice guidelines 2022 in China: a survey by Chinese redwood experts
    Jianjun Qin, Xufeng Guo, Yang Hu, Xiangnan Li, Zhuoyi Li, Jiangbo Lin, Xinyu Mei, Peng Tang, Changchun Wang, Feng Wang, Hongyan Wang, Jun Yin, Yong Yuan, Jinbo Zhao, Zhigang Li, Yin Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (04): 195-199. DOI: 10.3877/cma.j.issn.2095-8773.2023.04.01
    Abstract (239) HTML (8) PDF (1176 KB) (45)

    The quality of clinical trials on esophageal cancer in Japan is very high, and its practice guidelines are unique in the world. In recent years, the clinical research of esophageal cancer in China has entered a new stage of development, and the number of clinical trials ranks among the top in the world. Some esophageal surgery experts in China discussed and reviewed the clinical issues related to surgery in the Japanese guidelines and voted on whether the relevant recommendations could be accepted in China. It is hoped that the introduction of the voting results can provide a reference for Chinese thoracic surgery colleagues.

  • 6.
    The staging evolution and treatment strategies of stage ⅠB non-small cell lung cancer
    Leilei Shen, Yang Liu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2022, 09 (04): 246-254. DOI: 10.3877/cma.j.issn.2095-8773.2022.04.09
    Abstract (130) HTML (7) PDF (1367 KB) (40)

    As the TNM staging system continues to update, the definition and classification of stage ⅠB non-small cell lung cancer (NSCLC) is also adjusted. Although it is an early-stage tumor, the risk of recurrence and metastasis is still high, and the 5-year overall survival is still a concern. The 8th edition of the TNM staging system raised T2b (4 cm<T2b≤5 cm) to stage ⅡA, highlighting the poor prognosis and the importance of adjuvant therapy, but the adjuvant treatment for stage IB (3 cm<T2a≤4 cm) has been controversial. At present, the consensus of most clinicians is recommending a multidisciplinary comprehensive evaluation to patients who have high risk factors after stage ⅠB surgery, and adjuvant chemotherapy can be considered based on the patient’s wishes. In recent years, targeted therapy has gradually become the first-line treatment for driver gene-positive NSCLC. The ADAURA trial showed that osimertinib can reduce the risk of postoperative recurrence in ⅠB NSCLC (AJCC version 7) . Adjuvant chemotherapy or osimertinib can be considered in stage ⅠB patients with high risk factors based on multidisciplinary evaluation and patients’ will. Good major pathological response (MPR) was achieved in the application of neoadjuvant chemotherapy or neoadjuvant immunotherapy for patients with stage ⅠB–ⅢA NSCLC. Further phase 3 RCTs to validate the effect are needed. Stereotactic body radiation therapy or ablation therapy is also a great surrogate for patients with early-stage inoperable NSCLC. In this article, the evolution of stage ⅠB NSCLC, current diagnosis and treatment strategies will be reviewed, which will provide some bases and references for our clinical practice.

  • 7.
    Research progress of spread through air space on lung adenocarcinoma
    Xiao Chen, Changqing Liu, Hangcheng Zhou, Tian Li, Xiaohui Sun, Mingsheng Wu, Liangdong Xu, Meiqing Xu, Mingran Xie
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (02): 126-130. DOI: 10.3877/cma.j.issn.2095-8773.2023.02.10
    Abstract (106) HTML (2) PDF (659 KB) (37)

    The World Health Organization (WHO) recognized spread through air space (STAS) as a new invasive form of lung cancer in 2015. STAS has a close relationship with tumor histology, clinical stage, lymphatic invasion, and vascular invasion as a risk factor for poor patient prognosis. STAS research has crucial implications for patients with lung adenocarcinoma’s long-term prognosis. This page discusses STAS’s definition, potential mechanisms, association with various pathological forms of lung cancer, surgical procedures, prognosis, and current disputes.

  • 8.
    Double sleeve uniportal video-assisted thoracoscopic lobectomy—a retrospective study from shanghai pulmonary hospital
    Jianqiao Cai, Jing Huang, Lei Jiang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2022, 09 (03): 144-149. DOI: 10.3877/cma.j.issn.2095-8773.2022.03.03
    Abstract (199) HTML (5) PDF (2055 KB) (37)
    Objective

    The cases of double sleeve uniportal thoracoscopic lobectomy in Shanghai Pulmonary Hospital were retrospectively analyzed and the key points of operational technique were summarized, to further discuss and explore the operation effects and application values.

    Methods

    A total of 47 patients who underwent double sleeve uniportal thoracoscopic lobectomy in Shanghai Pulmonary Hospital from June 2015 to January 2021 were consecutively enrolled. Patients were followed up remotely by telephone every 6 months post-operation. The operation duration, intraoperative bleeding, drainage volume on the first day after operation, postoperative hospital stay, complications and 1- and 2-year survival rates were recorded and analyzed.

    Results

    A total of 41 males and 6 females were enrolled, with an age of (60.5±8.0) years. 41 (87.2%) cases received left upper lobe double sleeves lobectomy, 3 (6.4%) cases received right upper lobe double sleeves lobectomy and 3 (6.4%) cases received right and middle double sleeves bilobectomy. The main pathological type was squamous cell carcinoma (30, 63.8%) . There were 9 (19.1%) , 17 (36.2%) and 21 (44.7%) of patients who had TNM stages of stage I, II and III, respectively. The mean operation duration was (2.7 ± 0.8) h, the mean intraoperative blood loss was (168.1±160.0) mL, and the mean postoperative hospital stay was (5.9±2.9) days. There was no case conversing to thoracotomy. The median follow-up time was 27 months. The 1-year overall survival rate was 87.9% and the 2-year overall survival rate was 68.7%.

    Conclusions

    Double sleeve uniportal thoracoscopic lobectomy can be used to completely remove tumors and preserve lung function to the greatest extent with reduced surgical traumas. This operation is technique-demanding, which is feasible and safe when carried out in thoracic centers with endoscopy proficiency.

  • 9.
    Uniportal video-assisted thoracoscopic right upper lobectomy
    Lei Li, Zuodong Song, Zhigang Huang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (01): 45-49. DOI: 10.3877/cma.j.issn.2095-8773.2023.01.08
    Abstract (256) HTML (32) PDF (3063 KB) (35)

    电视辅助胸腔镜肺外科手术(video-assisted thoracic surgery,VATS)在早期肺癌手术中的治疗价值目前已经得到广泛共识[1,2,3],ⅠA期肺癌行胸腔镜手术是指南推荐的手术方式。近年来,单孔腔镜技术随经验积累已经较广泛地开展和普及。相比传统腔镜手术,单孔技术可减少切口创伤,进而可能改善术后疼痛和患者体验[4]。另一方面,三维可视化系统也逐渐应用于VATS手术,与传统的二维VATS相比,该系统可提高可视化深度,增加操作的精细程度[5]。有报道指出,在接受VATS术的患者中,三维内窥镜视力对围手术期或肿瘤学结局或成本没有明显影响,但它可以减少手术时间(减少了17%)[6]。有研究表明,手术时间越长,肺叶切除术的结局越差;多变量分析发现,手术时间与并发症的发生率较高以及住院时间延长相关,是围手术期需要考虑的潜在危险因素[7]。大多数原发性肺癌(29.9%~37.2%)发生在右肺上叶,右上叶切除术涉及最复杂的肺门解剖结构,需要各种外科手术[8]。目前单孔VATS和三维可视化技术结合下的精确早期肺癌切除是一种安全可行的技术[9,10,11]

  • 10.
    Surgical treatment of primary peripheral pulmonary mucoepidermoid carcinoma in children: a case report and literature review
    Ruishi Wei, Jie Ma, Xinhua Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (02): 106-110. DOI: 10.3877/cma.j.issn.2095-8773.2023.02.07
    Abstract (43) HTML (5) PDF (2444 KB) (33)

    黏液表皮样癌(mucoepidermoid carcinoma,MEC)是一种好发于泪腺或涎腺的恶性肿瘤,起源于气管或支气管黏膜分泌腺的恶性肿瘤称为肺黏液表皮样癌(pulmonary mucoepidermoid carcinoma,PMEC)。PMEC为肺部肿瘤中一种罕见的恶性肿瘤,约占肺原发恶性肿瘤的0.1%~0.2%[1]。PMEC的临床及影像学表现无特异性,极易误诊及漏诊。因此,提高对该病的认识至关重要。本文就收治的1例儿童PMEC患者,结合近10年中外数据库中PMEC的相关文献,总结其临床特点,展开论述。

  • 11.
    Progress in diagnosis and treatment of tracheoesophageal fistula associated with thoracic malignancy
    Chang Yuan, Zhigang Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (04): 241-246. DOI: 10.3877/cma.j.issn.2095-8773.2023.04.09
    Abstract (83) HTML (4) PDF (1221 KB) (30)

    Tracheoesophageal fistula (TEF) associated with thoracic malignancy can seriously affect patients’ long-term survival. Most of these patients have poor basic conditions and can only choose palliative treatment. Preventing TEF and diagnosing it early is key to potentially improving its long-term prognosis. The emergence of new diagnostic and treatment technologies has brought new hope to these patients. This article summarized the progress and prospect of thoracic tumor-related TEF in four parts: pathogenesis, diagnosis and classification, treatment and prognosis, hoping to provide some reference for clinical work.

  • 12.
    Minimally invasive surgery of modified Nuss technique without being turned over for the treatment of adult recurrent pectus excavatum
    Hao Li, Zhijun Zhu, Lei Wang, Fengqing Hu, Guoqing Li, Mingsong Wang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (03): 131-136. DOI: 10.3877/cma.j.issn.2095-8773.2023.03.01
    Abstract (67) HTML (5) PDF (1665 KB) (27)
    Objective

    To access the efficacy and safety of minimally invasive surgery of modified Nuss technique without being turned over for the treatment of adult recurrent pectus excavatum.

    Methods

    From July 2008 to September 2021, 48 adult recurrent pectus excavatum cases were treated with minimally invasive surgery of modified Nuss technique without being turned over in the Department of Thoracic Surgery of Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and in the Department of Cardiothoracic Surgery of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, among which 22 cases were performed previously by Ravitch procedure, 23 cases were Nuss procedure, 2 cases were Ravitch combined with Nuss procedure, 1 case was uncertain respectively.

    Results

    All 48 cases were performed by minimally invasive surgery of modified Nuss technique without being turned over successfully. The average postoperative hospital stays were 5.58 days. The Hallex index was improved. The complications were mild. The patients were all satisfied with their chest appearance after the operation.

    Conclusions

    Minimally invasive surgery of modified Nuss technique without being turned over is effective and safe, which will be a surgical choice for the treatment of adult recurrent pectus excavatum in the future.

  • 13.
    Uniportal video-assisted thoracoscopic sleeve lobectomy of right upper lobe
    Zuodong Song, Xinghua Cheng
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (03): 180-182. DOI: 10.3877/cma.j.issn.2095-8773.2023.03.08
    Abstract (170) HTML (21) PDF (1039 KB) (26)

    近年来,胸腔镜手术已成为许多有经验的医疗中心的首选手术方法,目前胸腔镜手术通常采用2~4孔法。单孔腔镜技术是在传统胸腔镜技术上,只留一个3 cm左右的孔,同时作为观察孔和操作孔,但因为其操作相对困难,目前尚未广泛应用[1,2,3,4,5]。根据经验,在经过一定量的训练后,单孔腔镜技术可以顺利完成较为复杂的解剖性肺切除手术,其有效性及安全性都是值得信任的。肺袖状切除手术被认为是一项具有挑战性的胸外科手术,该术式最初用于无法耐受全肺切除的患者,目前已被认为是一种比全肺切除更适合肿瘤的治疗方法[6,7]。临床上,单孔腔镜技术结合肺袖状切除技术会更具挑战性,现展示1例单孔腔镜右上肺袖状切除病例。

  • 14.
    The surgery of thymoma: how to choose
    Leilei Shen, Yang Liu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (04): 224-227. DOI: 10.3877/cma.j.issn.2095-8773.2023.04.05
    Abstract (102) HTML (9) PDF (1146 KB) (24)

    Thymoma is the most common tumor of the anterior mediastinum, and complete surgical resection is an important factor for the patient's recurrence and survival. With the update of minimally invasive surgical concepts and the development of devices, the surgical treatment of thymoma has gradually diversified, but the choice is controversial.

  • 15.
    Pulmonary myelolipoma: a case report and related research report
    Wenjun Cao, Hongsheng Xue, Zhe Pu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2022, 09 (04): 264-266. DOI: 10.3877/cma.j.issn.2095-8773.2022.04.11
    Abstract (54) HTML (3) PDF (1904 KB) (24)

    1905年,髓脂肪瘤被首次描述,是一种罕见的间质来源的良性肿瘤,由成熟的脂肪组织和造血组织按照不同的比例混合组成,最常见于肾上腺,其次为骶前区或腹膜后[1]。1996年,Zoilkowlski首次报道了肺髓脂肪瘤。检索中国知网和PubMed数据库发现已报道的肺髓脂肪瘤仅18例,约占所有髓脂肪瘤的3%[2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17]。现将大连大学附属中山医院收治的1例肺原发性髓脂肪瘤结合既往报道的病例特点报告如下。

  • 16.
    A standard animal model of lobectomy—basic anatomy of swine lung
    Liru Chen, Zhigang Li, Chunguang Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2024, 11 (01): 16-22. DOI: 10.3877/cma.j.issn.2095-8773.2024.01.02
    Abstract (417) HTML (9) PDF (3094 KB) (23)
    Objective

    To display the anatomy of swine lung lobes, especially the characteristics of bronchus, pulmonary arteries and pulmonary veins of each lung lobe, in order to provide reference for animal experiments of lobectomy.

    Methods

    The heart and lung organs of an adult pig were extracted to observe the structure of the lung lobes. Further, the lung of the pig was dissected at the level of lung lobes to observe the anatomical characteristics of the bronchus, pulmonary arteries and pulmonary veins.

    Results

    Swine lungs are divided into left and right lungs. The left lung has 3 lobes, namely apical lobe, cardial lobe and diaphragmatic lobe, in which the left apical lobe and left cardial lobe are fused. The right lung has 4 lobes, namely apical lobe, cardial lobe, diaphragmatic lobe and accessory lobe. Each lobe has independent bronchus, pulmonary artery and pulmonary vein. The left apical lobe and left cardial lobe bronchus are co-stem, which is similar to the human left upper lobe bronchus. Two pulmonary arteries branch into the left apical lobe, and only one pulmonary artery branch into the left diaphragmatic lobe and each lobe of the right lung. There are two pulmonary veins in the right accessory lobe. One of the accessory pulmonary veins joins at the root of the pulmonary veins in the diaphragmatic lobe and enters the pericardium, while any of other pulmonary lobes has only one pulmonary vein.

    Conclusions

    The anatomical characteristics of bronchus, pulmonary arteries and pulmonary veins of swine lung are similar to those of human lung, and can be used as an animal model for lobectomy. Familiarity with the anatomy of swine lung is helpful to carry out relevant experiments and studies.

  • 17.
    Progress in surgical treatment of multiple pulmonary nodules
    Zhiyu Wang, Runyi Tao, Jinteng Feng, Kun Fan, Hongyi Wang, Heng Zhao, Bohao Liu, Yixing Li, Yanpeng Zhang, Jia Zhang, Guangjian Zhang, Junke Fu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2021, 08 (02): 108-112. DOI: 10.3877/cma.j.issn.2095-8773.2021.02.06
    Abstract (112) HTML (2) PDF (1224 KB) (23)

    With the development of science and technology as well as the popularization of lung cancer screening, the discovery rate of pulmonary nodules has gradually increased, many of which are multiple pulmonary nodules. In many cases, the diagnosis cannot be confirmed only by radiologic appearance, where surgical intervention is required for diagnosis and treatment. However, currently there are no clear and unified guidelines for the surgical treatment of multiple pulmonary nodules, especially for the treatment of sub-centimeter pure ground-glass nodules and the remaining nodules after resection of the primary lesions. This article collects and summarizes the treatment of multiple pulmonary nodules mentioned in several guidelines.

  • 18.
    Hemi-thymectomy as a new approach to early-stage thymic epithelial tumors and benign thymic lesions
    Songyuan Guo, Fenghao Yu, Zhitao Gu, Teng Mao, Wentao Fang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (01): 1-6. DOI: 10.3877/cma.j.issn.2095-8773.2023.01.01
    Abstract (84) HTML (9) PDF (1556 KB) (23)
    Objective

    For early-stage thymic epithelial tumors (TETs) , advocation for partial thymectomy or even thymomectomy has always existed. The concept of hemi-thymectomy is based on the anatomical structure of the thymus; and it is devised to be applied to early-stage TETs and benign thymic lesions located entirely on one lobe of the thymus. This article summarized our preliminary experience with this novel surgical extent including both peri-operative outcomes and short-term prognosis.

    Methods

    Over a 12-month period, a total of 31 patients underwent minimally invasive hemi-thymectomy. The clinical characteristics, co-morbidities, peri-operative results, final pathology and short-term prognosis of these patients were summarized.

    Results

    A total of 11 males and 20 females with a mean age of 52.7 (35–77) years underwent minimally invasive hemi-thymectomy for their anterior mediastinal lesions. Twenty-six of them had various degrees of co-morbidities: 12 with overweight, 9 with hypertension, 3 with diabetes mellitus, 1 with leukopenia and 1 with endometrial stromal sarcoma. All 31 hemi-thymectomies via the anterolateral minimally invasive approach were successful without intra-operative adverse events. The mean operation time was 60.83 (31–91) min. The mean intra-operative blood loss was 49.5 (20–200) mL. There were no deaths in peri-operative period. The mean post-operative hospital stay was 1.3 (1–2) days; the mean drainage volume on the first post-operative day was 77.8 (0–350) mL. The mean chest drainage tube indwelling time was 0.7 (0–2) days. Drainage tubes of 10 patients were removed within 24 hours after the surgery. The pathology results showed 21 thymomas, 7 teratomas and 3 hemangiomas. All 21 thymomas were UICC pT1aN0M0. No recurrence was observed during the follow-up (6–12 months) .

    Conclusions

    Hemithymectomy, a new range of thymectomy based on thymic anatomy, is used to treat early-stage, non-myasthenia gravis-derived tumors of thymic epithelial origin and benign lesions located in one thymus. Preliminary exploration suggests that this is a safe and effective resection method with good perioperative and short-term oncological outcomes. In theory, hemithymectomy has inherent advantages over traditional total thymectomy, and can provide a faster and safer surgical experience for a selected group of patients.

  • 19.
    Effects of protein regulator of cytokinesis 1 on migration, invasion and proliferation of lung adenocarcinoma cell
    Shihao Li, Zihao Li, Bo Dong, Chunli Wu, Bin Wu, Yinliang Sheng, Yu Qi
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (03): 164-175. DOI: 10.3877/cma.j.issn.2095-8773.2023.03.06
    Abstract (65) HTML (4) PDF (7881 KB) (23)
    Objective

    To investigate the effect of protein regulator of cytokinesis 1 (PRC1) on lymph node metastasis, migration, proliferation and prognosis of lung adenocarcinoma.

    Methods

    The non-small cell lung cancer expression matrix was obtained from Gene Expression Omnibus (GEO), including GSE7670, GSE32863 and GSE68465. Firstly, differential analysis was performed on the three datasets to obtain differentially expressed genes, which were then subjected to enrichment analysis. Secondly, the clinical and expression data of differentially expressed genes were obtained from The Cancer Genome Atlas (TCGA) database. The data was used for weighted gene co-expression network analysis (WGCNA) to obtain the module most relevant to clinical characteristics including tumor stage and lymph node metastasis. Thirdly, the hub gene was obtained through analysis of the module genes using the Search Tool for the Retrieval of Interaction Genes/Proteins (STRING) and binary logistic regression analysis. Subsequently, the expression level of PRC1 in both mRNA and protein levels between lung adenocarcinoma and normal tissues was validated. After knocking down the expression of PRC1 in human lung adenocarcinoma cell line H1299, in vitro functional experiments were conducted to validate the impact of PRC1 on the proliferation, migration, and invasion abilities of lung adenocarcinoma cells. T-test was used to compare the difference of PRC1 expression between normal and tumor tissues, and binary logistic regression analysis was performed to identify independent factors affecting tumor prognosis. Additionally, the downstream mechanism of PRC1 in regulating the metastasis of lung adenocarcinoma cells was investigated.

    Results

    The expression level of PRC1 was higher in lung adenocarcinoma tissues compared to normal lung tissues, at both mRNA and protein levels, with statistical significance. The cells in the Si-PRC1 group were significantly lower than that in the control group in migration experiments (P<0.001), invasion experiments (P<0.001), and scratch experiments (P<0.001). The proliferation ability of Si-PRC1 group cells was significantly lower than that of the control group at 72 and 96 hours. Patients with high expression of PRC1 in lung adenocarcinoma had shorter overall survival (P=0.0014). The qPCR results showed that E-cadherin expression was significantly upregulated (P<0.001) in PRC1 knockdown cells, while N-cadherin and Vimentin expression were significantly downregulated (P<0.01). Western blot results showed that the activated phosphorylated MAPK signal was weakened in PRC1 knockout tumor cells.

    Conclusions

    PRC1 is associated with poor prognosis of LUAD patients and affects lymph node metastasis and tumor cells proliferation, migration and invasion. PRC1 is a potential therapeutic target for lung adenocarcinoma.

  • 20.
    Uniportal thoracoscopic right upper lobectomy: a case series of double-stapling technique
    Wei Luo, Yize Li, Ran Cao, Xugang Zhang, Qing Yin, Kun Wang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2023, 10 (04): 200-206. DOI: 10.3877/cma.j.issn.2095-8773.2023.04.02
    Abstract (96) HTML (4) PDF (3129 KB) (22)
    Objective

    To retrospectively analyze the patients who underwent uniportal thoracoscopic right upper lobectomy using double-stapling vs traditional technique at Anning First People's Hospital Affiliated to Kunming University of Science and Technology. Compare the differences between the double-stapling technique and traditional technique in the application of uniportal thoracoscopic right upper lobe resection, summarize the key points of the double-stapling surgical technique, and explore the surgical results and promotional value.

    Methods

    Forty-nine patients from July 2021 to May 2023 were consecutively enrolled at Anning First People's Hospital. A total of 22 patients underwent uniportal thoracoscopic two-stapler resection of the right upper lobe. A total of 27 patients underwent uniportal thoracoscopic right upper lobectomy using traditional methods. The outcome measures were operative time, intraoperative bleeding, drainage tube duration and postoperative hospital stay.

    Results

    For the double-stapling technique group, 22 patients (16 males, 6 females) were enrolled. The median age was (58.00±9.38) years old. There were no cases converted to thoracotomy. The mean operative duration was (84.86±15.81) min, the mean intraoperative blood loss was (73.86±21.98) mL, the mean drainage tube duration was 2.00 (1.00, 2.00) days, and the mean postoperative hospital stay was 5.00 (4.75, 6.00) days. For the traditional technique group, 27 patients (13 males, 14 females) were enrolled. The median age was (58.46±8.63) years old. The mean operative duration was (93.55±13.43) min, the mean intraoperative blood loss was (85.34±20.22) mL, the mean drainage tube duration was 2.00 (1.00, 3.00) days, and the mean postoperative hospital stay was 5.00 (4.50, 6.00) days. The shorter surgical operative time for the double-stapling technique was statistically significant (P<0.05) .

    Conclusions

    Compared to traditional techniques, uniportal thoracoscopic double-stapling technique for right upper lobectomy has a shorter operative time while also achieving a curative effect. The operative process is simple, easy to perform, safe, reliable, and benefits patients while reducing their economic burden.

京ICP 备07035254号-28
Copyright © Chinese Journal of Thoracic Surgery(Electronic Edition), All Rights Reserved.
Tel: 021-61675196 Fax: (010)85158381 E-mail: editor@thecjts.cn
Powered by Beijing Magtech Co. Ltd